Speclipse Holds Grand Opening of PICO-K in Thailand with Over 80 Dermatologists in Attendance

Local dermatologists are sharing their clinical experiences with PICO-K at the “PICO-K Grand Opening 2025” in Bangkok, Thailand.

Speclipse, Inc. a leading medical technology company specializing in laser- and AI-based skin treatment and skin cancer diagnostics, successfully hosted the PICO-K Grand Opening 2025 (Thailand) to mark the official launch of its flagship device, PICO-K, in the Thai market.
 
The event took place on July 16 in Bangkok, drawing over 80 prominent Thai dermatologists who gathered to learn about Speclipse’s cutting-edge technology and brand vision. Speclipse executives, including CEO Jeong-Hwan Hong, Executive Directors Sung-Hyun Pyun and Tae-kyun Kim, attended the event along with Sanghoon Lee, CEO of Beauty Solution Co., LTD (BTS), Speclipse’s local partner in Thailand.
 
Beyond a simple product introduction, the event showcased clinical comparison data between PICO-K and other leading global picosecond laser systems, highlighting the device’s advanced capabilities. According to the presented results, PICO-K demonstrated faster improvement rates and more consistent treatment outcomes across various indications including pigmented lesions, scars, and enlarged pores, outperforming several established competitors.
 
A highlight of the evening was a live session where leading Thai dermatologists—Dr. Vassanop, Dr. Paisan, Dr. Nititam, and Dr. Harirak—shared their real-world experiences using PICO-K in clinical settings. They noted the system’s superior output precision, predictable treatment response, and enhanced skin reaction, stating that “The difference is clearly visible not only in the technical specifications but also in actual patient outcomes.”
 

The session served as a platform for these physicians to share detailed insights on treatment techniques, device settings, and practical advantages of PICO-K with their peers.  

PICO-K, the picosecond laser device developed by Speclipse, was on display at the event venue

 
PICO-K is a high-powered picosecond laser system independently developed by Speclipse, designed to provide a premium solution for a wide spectrum of dermatological indications such as pigmented lesions, acne scars, and enlarged pores.
It features an ultra-short pulse duration of 300 picoseconds and delivers peak power up to 2.0 GW, ensuring precise energy delivery and superior pulse stability—key factors in achieving highly predictable and safe treatment outcomes.
 
“This event marks more than just a product launch; it is the beginning of long-term collaboration and knowledge sharing in the Thai medical aesthetics market,” said Jeong-Hwan Hong, CEO of Speclipse.
“We are committed to building strong relationships with local practitioners and growing together based on mutual trust.”
 
Speclipse continues to expand its global presence through a combination of regulatory approvals, product certifications, and strategic partnerships in Malaysia, Taiwan, Vietnam, the UAE, and across Europe—solidifying its reputation as a leading K-Medical brand in the global aesthetic and diagnostic device industry.
 

강동현 기자 [email protected]